Engineers Gate Manager’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$522K Sell
66,556
-10,291
-13% -$81.3K 0.01% 1484
2026
Q1
$522K Buy
76,847
+51,606
+204% +$381K 0.01% 1393
2025
Q4
$294K Sell
25,241
-44,302
-64% -$490K ﹤0.01% 1649
2025
Q3
$809K Buy
69,543
+52,509
+308% +$635K 0.01% 1262
2025
Q2
$210K Sell
17,034
-17,128
-50% -$189K ﹤0.01% 1877
2025
Q1
$210K Buy
34,162
+16,325
+92% +$169K ﹤0.01% 1876
2024
Q4
$144K Buy
+17,837
New +$178K ﹤0.01% 1951
2024
Q3
Sell
-11,843
Closed -$51.3K 2163
2024
Q2
$51.3K Sell
11,843
-880
-7% -$4.47K ﹤0.01% 1812
2024
Q1
$53.9K Buy
+12,723
New +$44.1K ﹤0.01% 1806

Other funds holding CRMD

Engineers Gate Manager's CRMD Position: Q2 2026 in Review

Engineers Gate Manager reduced its CorMedix (CRMD) stake by 13% in Q2 2026, selling an estimated $81.3K and leaving 66,556 shares worth $522K. The position accounts for 0.01% of the portfolio, ranked #1484.

Engineers Gate Manager first reported a position in CRMD in Q1 2024 and has held it in 9 quarters since. The position peaked at $809K in Q3 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Engineers Gate Manager held 66,556 shares of CorMedix worth $522K as of Q2 2026.
  • Engineers Gate Manager sold 10,291 CorMedix shares in Q2 2026, an estimated $81.3K.
  • CorMedix made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1484 holding.
  • Engineers Gate Manager first reported a position in CorMedix in Q1 2024 and has held it in 9 quarters since.
  • Engineers Gate Manager's CorMedix position peaked at $809K in Q3 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.